Context Therapeutics Inc.

For the period ended Dec 31, 2024. Filed Mar 20, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 20, 2025

CNTX$0.20+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$94,429,824	$14,449,827
Prepaid expenses and other current assets	3,466,160	1,597,384
Total current assets	97,895,984	16,047,211
Operating lease right-of-use asset	218,816	—
Property and equipment, net	11,959	15,524
Total assets	$98,126,759	$16,062,735
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$1,452,188	$2,383,016
Accrued expenses and other current liabilities	1,188,929	1,808,699
Operating lease liability - current	107,316	—
Total current liabilities	2,748,433	4,191,715
Operating lease liabilities - non-current	112,064	—
Total liabilities	2,860,497	4,191,715
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding	—	—
Common stock—$0.001 par value; 200,000,000 and 100,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; 89,704,194 and 15,966,053 issued and outstanding at December 31, 2024 and December 31, 2023, respectively	89,704	15,966
Additional paid-in capital	189,956,252	79,909,644
Accumulated deficit	(94,779,694)	(68,054,590)
Total stockholders' equity	95,266,262	11,871,020
Total liabilities and stockholders' equity	$98,126,759	$16,062,735

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.